Tony Breu Profile picture
Oct 31, 2021 15 tweets 7 min read Read on X
1/15
Why are statins administered at night?

In this tweetorial I'll discuss the mechanistic and historical reasons for the frequently used QHS dosing schedule. And why it's often unnecessary.

But before we get there, I'm curious: when do you prescribe/order/take statins?
2/
Early studies suggested that evening administration of statins led to a greater reduction in cholesterol when compared with morning dosing.

Two notes on the linked study:
➤It is small
➤The differences in LDL reduction weren't as clear

PDF: t.ly/6wfc Image
3/
As a result of this early data, the package insert for lovastatin, the first FDA-approved statin, suggested evening dosing.

And the landmark 4S trial did the same, administered simvastatin in the evening.

Insert: t.ly/GsOy
4S: t.ly/9mqS ImageImage
4/
Any many hospitals, including my own, still default to evening dosing for statins.

Here are screenshots for simvastatin and atorvastatin. Image
5/
To understand why evening dosing is often recommended, we must recall the mechanism of action of statins.

These medications work by inhibiting HMG CoA reductase, the rate-limiting enzyme in the cholesterol biosynthetic pathway.

PDF: t.ly/US6B Image
6/
Early data using mevalonate (a surrogate for cholesterol synthesis) suggested that...

🔑HMG CoA reductase activity has a diurnal rhythm with peak activity between midnight and 6am.

PDF: t.ly/arrV Image
7/
More recent data using direct measures of cholesterol have found a similar spike after midnight.

This is likely due to a combination of both the circadian rhythms of enzyme activity and increased activity when fasting.

PDF: t.ly/WzGT Image
8/
🔑But the finding that evening administration leads to greater reductions in cholesterol doesn't seem to be a class effect.

For example, one study of atorvastatin dosing found a 47% reduction in LDL with BOTH morning and evening dosing.

PDF: t.ly/VxlL Image
9/
So: simvastatin seems to work better when dosed in the evening while the timing of atorvastatin administration doesn't seem to matter.

What's different about atorvastatin, when compared with simvastatin, that explains this finding?
10/
The most relevant difference is likely half-life. Notice the difference:

Simvastatin: 2-3 hours
Lovastatin: 2.9 hours
Atorvastatin: 15-20 hours

PDF: t.ly/1V01 Image
11/
In meta-analyses, the difference between evening and morning dosing is significantly greater for statins with short half-lives.

For long-acting statins:
➤Total cholesterol is not affected by timing
➤LDL is minimally better with evening dosing

PDF: t.ly/VCg5 Image
12/
Going back to the original data, here's the reason evening dosing is superior for lovastatin and simvastatin:

🔑These statins have short half-lives. By giving them at night, you ensure they work on their target enzyme (HMG CoA reductase) when its activity is highest.
13/
Does it matter that many still default to evening dosing of ALL statins, despite little to no difference for long-acting versions?

Given that some data shows that adherence is higher for morning medications, it just might.

PDF: t.ly/g9mo Image
14/
Before closing, I'm again curious: what will you do now?

Will do prescribe/order/take only in the morning (to increase adherence), evening (maybe it's better), modify based on the statin half-life, or ask the patient what you'd prefer?
15/15
☞ HMG CoA reductase activity is highest overnight
☞ Based on this, statins with short half-lives may be more effective when taken at night
☞ For statins with longer half-lives, timing likely does not matter

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Tony Breu

Tony Breu Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @tony_breu

Jun 20
1/11
🤔Why does chronic hepatitis C infection "require" the intermediary of cirrhosis in order to cause hepatocellular carcinoma (HCC)?

Chronic hepatitis B can "skip" this step, going directly from chronic infection to HCC.

Why the difference?
2/
To begin, let's look at how frequently HCC occurs in patients without cirrhosis.

A 2019 study of United States (US) medical centers included 5144 patients with HCC.

💡12% had no underlying cirrhosis

pubmed.ncbi.nlm.nih.gov/31475372/
3/
A 2022 study found a similar rate, with 13% of patients with HCC showing no evidence of cirrhosis.

When looking more specifically at hepatitis C (HCV) versus hepatitis B (HBV), they found varying rates:

➣ HCV: 6% of patients with HCC were non-cirrhotic
➣ HBV: 19% of patients with HCC were non-cirrhotic

pubmed.ncbi.nlm.nih.gov/34027591/Image
Read 11 tweets
Apr 9
1/12 - Mystery #1

You are seeing a patient recently diagnosed with heart failure and started on GDMT. You notice that their hemoglobin (HGB) has increased (12 → 13 g/dL) in the intervening weeks.

🤔Which medication is the likely cause of this increase in HGB?
2/12 - An Answer

Empagliflozin

💡All SGLT2 inhibitors have been associated with an increase in hematocrit/hemoglobin soon after initiation.

The average increase is 2.3% in hematocrit and 0.6 g/dL in hemoglobin.

ncbi.nlm.nih.gov/pmc/articles/P…Image
3/12 - An Initial Explanation (I)

The effect of SGLT2 inhibitors on HCT/HGB has been noted since the very first randomized control trial of dapagliflozin, published in 2010.

Initially, investigators assumed this was related to the diuretic effect of these drugs (i.e., a reduction in plasma volume led to an increase in HCT/HGB).

pubmed.ncbi.nlm.nih.gov/20609968/Image
Read 12 tweets
Feb 22
1/10
🤔Why is pulmonary embolism (PE) relatively rare in those with Factor V Leiden?

This Factor V Leiden Paradox was pointed out to me by @DrSamelsonJones after I posted about a similar difference with Behçet Syndrome.

Let's have a look.
2/
In 1993, Dahlback, Carlsson, and Svensson first described a heritable resistance to activated protein C.

A year later the same group found this to be the most common form of hereditary hypercoagulability.


ncbi.nlm.nih.gov/pmc/articles/P…
pubmed.ncbi.nlm.nih.gov/8302317/Image
Image
3/
The mutation in the Factor V gene conferring resistance to activated protein C was detailed the following year by a group in Leiden, The Netherlands.

Thus the name for the condition: Factor V Leiden.

pubmed.ncbi.nlm.nih.gov/8164741/Image
Read 10 tweets
Feb 18
1/8
🤔Why is pulmonary embolism (PE) so rare in Behçet Syndrome?

The condition is associated with a 14-fold increased risk of deep vein thrombosis (DVT) but almost none of these result in PE.

What is it about the thrombus in Behçet that makes it so unable to embolize?
2/
Numerous case series have reported a markedly increased risk of deep vein thrombosis with Behçet Syndrome.

One reported the following rates of venous thrombosis:
➣ Behçet Syndrome: 18/73 (25%)
➣ Controls: 4/146 (3%)

pubmed.ncbi.nlm.nih.gov/11426022/Image
3/
Another study of 882 patients with vascular Behçet Syndrome reported the following rates of deep vein thrombosis (DVT) and pulmonary embolism (PE):

➣ DVT: 592/882 (67%)
➣ PE: 0%!

pubmed.ncbi.nlm.nih.gov/24907156/Image
Read 9 tweets
Dec 12, 2023
1/7
🤔What is the hemodynamic response to a chronic hemoglobin of 1.5 g/dL.

A fascinating 1963 study published in @CircAHA provides some interesting answers. Let's have a look at Patient One.

ahajournals.org/doi/pdf/10.116…
Image
@CircAHA 2/
Patient One had chronic anemia with a hemoglobin 1.5 g/dL. You'll see that before receiving blood they had the following cardiac parameter:

• HR 100 (elevated)
• Cardiac index 8.9 (elevated)
• Stroke index 89 (elevated) Image
@CircAHA 3/
After transfusion to a hemoglobin of 10 g/dL, the following changes were noted:

• HR 100 (elevated but unchanged)
• Cardiac index 3.4 (decreased and now normal)
• Stroke index 34 (decreased and now normal)
Image
Image
Read 7 tweets
Dec 10, 2023
1/17
🤔Why don't we transfuse to a normal hemoglobin?

In many cases, we aim to restore values to the normal range. Potassium and other electrolytes. Even white blood cells.

But not hemoglobin.

In most situations, we accept >7g/dL, far less than normal. Why are we so tolerant? Image
2/
The principal rationale for red blood cell transfusion is to increase the O₂-carrying capacity and therefore O₂ delivery to tissues.

As hemoglobin is lowered O₂ delivery decreases, assuming all else remains unchanged.

So giving blood makes sense.
3/
Historically we did not transfuse to normal because we did not transfuse. The risks far outstripped the benefits.

There were also technical constraints and storage limitations. This meant that transfusions were reserved for acute conditions.

onlinelibrary.wiley.com/doi/pdfdirect/…
Image
Read 17 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(